Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 20, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Immune Spatial Organization Predicts Metastasis Risk in Aggressive Localized Prostate Cancer.

David D Yang, Aya Abdelnaser, Jeremiah Wala

    Biorxiv : the Preprint Server for Biology
    |June 6, 2025
    PubMed
    Summary

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Simulation and empirical evaluation of biologically-informed neural network performance.

    Machine learning with applications·2026
    Same author

    Evaluating agentic AI for biological discovery in autonomous and copilot settings.

    bioRxiv : the preprint server for biology·2026
    Same author

    Genomic analysis of BCG unresponsive non-muscle-invasive bladder cancer identifies drivers of sensitivity to intravesical Gemcitabine/Docetaxel.

    bioRxiv : the preprint server for biology·2026
    Same author

    Diverse mediators of cancer predisposition uncovered by germline whole genome sequencing of unexplained familial cancers.

    medRxiv : the preprint server for health sciences·2026
    Same author

    Genomic, Clinical, and Spatial Predictors of Durable Response to BRAF/MEK Inhibition in <i>BRAF</i>-Mutant Melanoma.

    bioRxiv : the preprint server for biology·2026
    Same author

    Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.

    Nature cancer·2026
    Same journal

    Whole-Embryo 3D Quantification Reveals Conserved Topological Design and Scaling of Germ Layers in Xenopus.

    bioRxiv : the preprint server for biology·2026
    Same journal

    scRNA-seq and genomics analyses reveal key mechanisms of inverted papilloma-associated sinonasal squamous cell carcinoma malignant transformation.

    bioRxiv : the preprint server for biology·2026
    Same journal

    M1C IS NECESSARY FOR DARAXONRASIB RESISTANCE OF NSCLC KRAS(G12C) MUTANT CELLS.

    bioRxiv : the preprint server for biology·2026
    Same journal

    A human-specific genetic modifier reconfigures large-scale cortical network dynamics underlying behavioral performance.

    bioRxiv : the preprint server for biology·2026
    Same journal

    <i>Staphylococcus aureus</i> uses a eukaryotic-like uridyltransferase to make UDP-GlcNAc for cell wall synthesis.

    bioRxiv : the preprint server for biology·2026
    Same journal

    Dynamic redistribution of eIF4F controls cap-dependent translation initiation.

    bioRxiv : the preprint server for biology·2026
    See all related articles
    This summary is machine-generated.

    Spatial clustering of immune cells in prostate cancer (PCa) predicts metastasis risk. This immune spatial architecture offers an interpretable biomarker for high-grade PCa, revealing an antitumor response.

    Area of Science:

    • Computational pathology
    • Cancer immunology
    • Prostate cancer research

    Background:

    • Risk stratification for localized prostate cancer (PCa) requires improvement.
    • Current computational pathology methods for PCa lack interpretability or focus only on tumor morphology.

    Purpose of the Study:

    • To identify, validate, and interpret an immune microenvironment-derived computational pathology biomarker for high-grade PCa.
    • To investigate the association between immune spatial architecture and distant metastasis risk in PCa.

    Main Methods:

    • Analysis of digitized hematoxylin and eosin (H&E)-stained slides from two independent patient cohorts (n=490).
    • Assessment of spatial clustering and abundance of immune cells.
    • Joint analysis of H&E images and RNA sequencing data (n=326).

    More Related Videos

    Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
    06:32

    Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

    Published on: November 4, 2022

    Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
    07:01

    Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

    Published on: August 29, 2016

    Related Experiment Videos

    Last Updated: May 20, 2026

    An Orthotopic Murine Model of Human Prostate Cancer Metastasis
    06:48

    An Orthotopic Murine Model of Human Prostate Cancer Metastasis

    Published on: September 18, 2013

    Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
    06:32

    Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

    Published on: November 4, 2022

    Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
    07:01

    Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

    Published on: August 29, 2016

    Main Results:

    • Spatial clustering of immune cells, not abundance, independently predicted reduced distant metastasis risk in high-grade PCa.
    • High-cluster samples in high-grade PCa were enriched with CD8+ T cells, activated memory CD4+ T cells, Tregs, and clonal T cell populations.
    • No significant immune cell enrichment or association with metastasis risk was observed in low-grade tumors.

    Conclusions:

    • Immune spatial architecture is a novel, interpretable computational pathology biomarker for high-grade PCa.
    • The findings suggest an underlying T cell-mediated antitumor response in high-grade PCa with specific immune microenvironment characteristics.
    • This study provides valuable insights into the immune landscape of high-grade prostate cancer.